Works matching IS 11732563 AND DT 2011 AND VI 31 AND IP 4
1
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 279, doi. 10.2165/00044011-200930100-8
- Article
2
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 269, doi. 10.2165/11586720-000000000-00000
- Article
3
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 257, doi. 10.2165/11539120-000000000-00000
- Article
4
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 247, doi. 10.2165/11586520-000000000-00000
- Article
5
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 237, doi. 10.2165/11586510-000000000-00000
- Article
6
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 231, doi. 10.2165/11540000-000000000-00000
- Article
7
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 221, doi. 10.2165/11539750-000000000-00000
- Article
8
- Clinical Drug Investigation, 2011, v. 31, n. 4, p. 213, doi. 10.2165/11586700-000000000-00000
- Article